CPRS Newsletter: "The Potential of Peptides in Modern Medicine"

November 12, 2025

Share This Page

CPRS Newsletter: "The Potential of Peptides in Modern Medicine"

November 12, 2025

Canadian Peptide Research Society (CPRS) Banner

Over 11% of new pharmaceutical entities approved by the FDA between 2016 and 2024 were synthetic peptides.  In 2023 alone, peptides accounted for 16.3% of novel therapeutics.

Dr Grant Pagdin

Dear Colleagues,

As the frontier of medicine continues to expand, peptides are emerging as a cornerstone of innovative therapies.  At CPRS, we are dedicated to accelerating this progress by fostering collaboration among clinicians, researchers, and industry leaders.

Why Are Peptides Changing the Landscape?

Peptides offer targeted, personalized treatment options with a growing portfolio of application - from regenerative medicine and autoimmune disorders to skin rejuvenation and metabolic health.  Our society champions rigorous research and responsible clinical adoption to ensure these therapies are safe and effective.

Canadian Peptide Research Society (CPRS) Resources Page on the website

What Can You Expect as a CPRS Member?

  • Access to cutting-edge research and white papers
  • Opportunities to contribute to and shape clinical guidelines
  • Networking with pioneers in peptide science and medicine
  • Participation in exclusive workshops and webinars

Join Us at Upcoming Conference

Meet members of CPRS, including Dr. Pagdin, to discuss how peptide therapies can revolutionize patient care:

Get Involved Today

Whether you're a clinician, researcher, or industry professional, your expertise can help drive peptide science forward.  Visit our website to learn more about membership benefits and how to become part of our vibrant community.

Together, we can unlock the full potential of peptides for better health outcomes.


Best regards,
Dr. Grant Pagdin
Canadian Peptide Research Society

Share This Page

CPRS Newsletter: "The Potential of Peptides in Modern Medicine"

November 12, 2025

Canadian Peptide Research Society (CPRS) Banner

Over 11% of new pharmaceutical entities approved by the FDA between 2016 and 2024 were synthetic peptides.  In 2023 alone, peptides accounted for 16.3% of novel therapeutics.

Dr Grant Pagdin

Dear Colleagues,

As the frontier of medicine continues to expand, peptides are emerging as a cornerstone of innovative therapies.  At CPRS, we are dedicated to accelerating this progress by fostering collaboration among clinicians, researchers, and industry leaders.

Why Are Peptides Changing the Landscape?

Peptides offer targeted, personalized treatment options with a growing portfolio of application - from regenerative medicine and autoimmune disorders to skin rejuvenation and metabolic health.  Our society champions rigorous research and responsible clinical adoption to ensure these therapies are safe and effective.

Canadian Peptide Research Society (CPRS) Resources Page on the website

What Can You Expect as a CPRS Member?

  • Access to cutting-edge research and white papers
  • Opportunities to contribute to and shape clinical guidelines
  • Networking with pioneers in peptide science and medicine
  • Participation in exclusive workshops and webinars

Join Us at Upcoming Conference

Meet members of CPRS, including Dr. Pagdin, to discuss how peptide therapies can revolutionize patient care:

Get Involved Today

Whether you're a clinician, researcher, or industry professional, your expertise can help drive peptide science forward.  Visit our website to learn more about membership benefits and how to become part of our vibrant community.

Together, we can unlock the full potential of peptides for better health outcomes.


Best regards,
Dr. Grant Pagdin
Canadian Peptide Research Society

Share This Page

Read The Latest